Ibsrela

Product manufactured by Ardelyx, Inc.

Application Nr Approved Date Route Status External Links
NDA211801 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ibsrela Is Indicated For Treatment Of Irritable Bowel Syndrome With Constipation (Ibs-C) In Adults. Ibsrela Is A Sodium/hydrogen Exchanger 3 (Nhe3) Inhibitor Indicated For Treatment Of Irritable Bowel Syndrome With Constipation (Ibs-C) In Adults. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Tenapanor Hydrochloride

Comments